title: [Management of brain metastases from urological malignancies].
abstract: Brain metastases account for 30 to 40% of all brain tumors in adults. Even if urological carcinomas are not very common, anti-angiogenic drugs have transformed their prognosis, leading physicians to consider their specific treatment. For the majority of cases, surgery is quite simple with low associated morbidity. Depending on the size and the location, surgery or stereotaxic radiotherapy should be discussed. As soon as the metastasis is suspected a neurosurgerical opinion must be sought before beginning any treatment to coordinate the global management.
authors.affiliation: Service de Neurochirurgie, Hôpital Foch, Frances. s.gaillard@hopital-foch.org
authors.forename: S
authors.initials: S
authors.lastname: Gaillard
authors.forename: T
authors.initials: T
authors.lastname: Lebret
authors.forename: P
authors.initials: P
authors.lastname: Scarone
authors.forename: J-F
authors.initials: JF
authors.lastname: Lepeintre
authors.forename: A
authors.initials: A
authors.lastname: Méjean
authors.forename: S
authors.initials: S
authors.lastname: Aldea
mesh_terms: D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D006801:Humans; D014571:Urologic Neoplasms / Q000473:pathology*